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1. Introduction 
A molecular model for the hypothalamic hormone 
LHRH, Py-His-Trp-Ser-Tyr -Gly-Leu-Arg-Pro- 
Gly-NH2, was proposed by Chang et al. [ 1 ] and the 
significance of the Arg side chain at position 8 was 
emphasized because of a postulated ionic interaction 
between the guanidino group and ‘a negative charge on 
the receptor site’. To obtain further information about 
this problem we studied the corresponding citrulline 
(Cit), homoarginine (Har) and lysine (Lys) [2,3] analogs. 
2. Materials and methods 
Cit*-LHRH (I) was obtained by condensation of 
Py-His-Trp-Ser-Tyr-Gly [4] (IV, RfA* 0.45-0.55, 
Rf" 0.15-0.25, Rf" 0.52-0.62) and Leu-Cit-Pro-Gly- 
NH2 (V, RfC 0.3-0.4, RfF 0.3-0.4) with dicyclohexyl- 
carbodiimide in the presence of pentachlorophenol 
[5]. Both I and II were prepared in a stepwise manner 
to avoid the risk of racemisation. Pure I was obtained 
by precipitation from hot ethanol (RF 0.33-0.43, 
R; 0.38-0.48, ok2 -27.8, (~1 in dimethylformamide, 
amino acid analysis gave correct ratios). 
Ha&LHRH (II): Z-Leu-Lys (Boc)-Pro-Gly- 
NH2 (VI, RfE 0.45-0.5) obtained in a stepwise manner 
* Solvent systems for TLC and column chromatography: A: 
ethyl acetate-pyridine-formic acid-water (20:20:6:6); 
B: ethyl acetate-pyridine-formic acid-water (30:20:6:6); 
C: ethyl acetate-pyridine-acetic acid-water (40:20:6: 11); 
D: ethyl acetate-pyridine-acetic acid-water (60:20:6:11); 
E: ethyl acetate--pyridine-acetic acid-water (240:20:6: 11); 
F: ethyl acetate-n butanol-acetic acid-water (1: 1: 1: 1). 
was treated with trifluoroacetic acid to yield the par- 
tially protected tetrapeptide (VII, RfD 0.7-0.8) 
which was reacted with 1-guanyl-3.5-dimethyl-pyrazole. 
The ensuing Har-derivative (VIII, Rf" 0.3-0.4) was 
purified by chromatography in a silica gel column using 
mixture E. After decarbobenzomylation the free te- 
trapeptide amide IX (RF 0.2-0.3) was coupled with 
IV to yield Il. The pure product was obtained by 
precipitation from water-ethanol (Rf 0.32-0.42, 
R; 0.4-0.5, c$j2 - 39.8, (~1 in 1% acetic acid, amino 
acid analysis gave correct ratios). 
Lys’-LHRH (Ill): VI was decarbobenzoxylated 
(X, RfD 0.45-0.55) and coupled with IV to give a 
crude decapeptide which was purified by chromato- 
graphy using the solvent mixture B. The pure product 
(Xl, RfB 0.42--0.52) was deblocked by trifluoroacetic 
acid-anisol-water (7:2: 1) mixture to afford Ill 
(Rp.0.32-0.42, RFO.4-0.5, CY~‘-49.3, c=l in 5% 
acetic acid, amino acid analysis gave correct ratios). 
3. Biological assay. Results 
The ovulation inducing activities of LHRH analogs 
have been studied in diestrus rats employing the 
method of Yamasaki and Nakayama [6] and in an- 
drogen sterilized female rats by a procedure developed 
in our laboratory [7]. 
LH-releasing activities of the LHRH analogs weie 
tested in ovariectomized, estrogen-progesterone 
blocked rats (OEP-rat), Ramirez and McCann [8]. The 
rats were used 3 months after ovariectomy, they were 
given 50 pg estradiolbenzoate and 25 mg progesterone 
in Ol.hel. 3 days prior to assay. The test materials 
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Table 1 
Ovulation-inducing activity of LHRH analogs in diestrus rats. (Synthetic LHRH and its analogs were 
administered by two subsequent S.C. injections) 
LHRH Har’-LHRH Cit*-LHRH 
Total dose 
rg/lOO g No. of Ovulating % No. of Ovulating % No. of Ovulating % 
body weight rats rats rats 
0.2 6 3 50 6 0 0 4 0 0 
0.8 5 5 100 7 3 43 7 1 14 
3.2 4 4 100 7 5 71 6 3 50 
Table 2 
Ovulation-inducing activity of LHRH analogs in androgen sterilized rats. (Androgen sterilization was performed by injecting 
testosterone (100 pg) into 3-day old female rats. LHRH and its analogs were administered by two subsequent S.C. injections) 
LHRH Har*-LHRH Cite-LHRH Lysa-LHRH 
total dose 
ng/lOO g No. of Ovulating 
body weight rats 
% No. of 
rats 
Ovulating % No. of 
rats 
Ovulating % No. of Ovulating % 
rats 
0.2 11 5 
0.4 8 8 
0.8 20 18 
1.6 
3.2 5 5 
6.4 5 5 
12.8 
44 4 0 0 4 
100 8 0 0 4 
90 13 8 61 3 
4 3 75 4 
100 4 4 100 4 
100 6 6 100 5 
0 0 
0 0 
0 0 3 0 0 
0 0 
2 50 4 2 50 
3 66 
5 5 100 
were injected into the tail vein. The effects of the 
analogs on plasma LH-activity following stimulation 
were followed by the ovarian ascorbic acid depletion 
assay (OAAD) [9]. 
As shown in table 1, SO%, 43% and 50% ovulation 
was caused by 0.2 pg LHRH, 0.8 pg Ha? -LHRH, and 
3.2 pg of Cit*-LHRH respectively. 
In androgen sterilized female rats (table 2) 0.2 pg 
LHRH, 0.8 pg Ha? -LHRH, 3.2 pg Cit’-LHRH, and 
3.2 Erg Lys’-LHRH yielded ovulation in 44, 61, 50 
and 50% of the animals respectively. The biological 
activity of Lys*-LHRH is known in the literature, it 
was only tested as a reference preparation. 
In our experiments LH-releasing activity of LHRH 
in the OEP-rats, as measured by bioassay, was generally 
seen at dose levels of 75-l 50 ng/rat i.v. 
The degrees of OAAD caused by 75-150 ng of 
234 
LHRH can be achieved with 145.9-540 ng of Hara- 
LHRH (extrapolated values) and 3 14.9-504.6 ng of 
Cit*-LHRH respectively (fig. 1). 
4. Discussion 
The postulated ionic interaction between the basic 
side chain of Arg* in the LHRH molecule and a ‘nega- 
tive charge’ on the receptor site was supported by the 
findings that lysine and ornithine derivatives retained 
lo-30% activity of the parent hormone while the 
neutral norvaline or leucine [IO] analogs were practi- 
cally inactive. The relatively high potency of Gln8 - 
LHRH reported by Yanaihara et al. [lo] , however, is 
not in full accord with this supposition. 
The hormonal evaluation of the neutral Cit8 -LHRH 
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x : 49 (75ng - f) 2 3 4 
75 450 300 600 
Dose: ng/rat i.v. 
Fig. 1. LH-Releasing activities of LHRH and of its analogs; bio- 
assayable LH in OEP-plasma, 15 min after i.v. injection, as 
measured by OAAD. OEP: ovariectomized, steroid-pretreated 
rats. 
has revealed that it shows 6-33s activity of the parent 
hormone depending on the assay used. So it can be 
presumed that the supposed ‘negative charge’ on the 
receptor site is that of a carboxyl group which can 
combine with the guanidino function of Arg’ through 
some bidentate structure formed by both ionic bonds 
and hydrogen bridges. Considering the data obtained 
for Cit’-LHRH (and for Glns derivative as well [lo] ) 
it is reasonable to assume that H-bridge forming capa- 
city of the side chain function may substitute the ionic 
bond in such bidentate structures, nevertheless the H- 
bridge bond or the electrostatic bond affords by itself 
a weaker interaction between the carboxyl group and 
the side chain function than together. 
Har8-LHFW retained 2550% of the biological 
potency of the native hormone indicating that the 
distance between the side chain function and the pep- 
tide backbone has a significant influence on the activity. 
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